Form4insider filings, from the source

SEC Form 4 · accession 0000904454-18-000051

Esperion Therapeutics, Inc. · ESPR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 24, 2018
Accepted (ET)
Jan 26, 2018 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 24, 2018J850,000—D1,037,852IBy Domain Partners VII, L.P.
Common StockF1,F3Jan 24, 2018J8,500—A8,500IBy One Palmer Square Associates VII, LLC
Common StockF2Jan 24, 2018M70,042$6.99A1,107,894IBy Domain Partners VII, L.P.
Common StockF2Jan 24, 2018F6,814$71.82D1,101,080IBy Domain Partners VII, L.P.
Common StockF4Jan 24, 2018M1,193$6.99A27,120IBy DP VII Associates, L.P.
Common StockF4Jan 24, 2018F117$71.82D27,003IBy DP VII Associates, L.P.
Common StockF5,F4Jan 25, 2018S11,674$71.79D15,329IBy DP VII Associates, L.P.
Common StockF6,F3Jan 26, 2018J8,500—D0IBy One Palmer Square Associates VII, LLC
Common StockF6Jan 26, 2018J645—A3,177D
Common StockF7holding———21,471IBy Domain Associates, LLC

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant to Purchase Common StockF2$6.99Jan 24, 2018M70,042DJul 1, 2013Feb 12, 2018Common Stock70,0420I
Warrant to Purchase Common StockF4$6.99Jan 24, 2018M1,193DJul 1, 2013Feb 12, 2018Common Stock1,1930I

Explanation of responses